Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1996 to 2010 of 7707 results

  1. MT660 CerebAir for monitoring continuous, real-time EEG

      Status ...

    Medical technologies guidance
    Topic selection

  2. MT658 Quit Genius for Smoking Cessation

      Status ...

    Medical technologies guidance
    Topic selection

  3. MT684 Smart Peak Flow for monitoring asthma

      Status ...

    Medical technologies guidance
    Topic selection

  4. Syne Covid for predicting COVID-19 outcomes MT655

      Status ...

    Diagnostics guidance
    Topic selection

  5. Kodex EPD system MT575 (MIB260)

      Status ...

    Medical technologies guidance
    Topic selection

  6. MTEP - Routing Butterfly IQ ultrasound scanner MT635 (MIB254)

      Status ...

    Medical technologies guidance
    Topic selection

  7. PROPEL (mometasone furoate implant, 370ug) MT578 (MIB253)

      Status ...

    Medical technologies guidance
    Topic selection

  8. microINR for anticoagulation therapy MT592 (MIB257)

      Status ...

    Medical technologies guidance
    Topic selection

  9. Woundexpress MT602 (MIB261)

      Status ...

    Medical technologies guidance
    Topic selection

  10. Pembrolizumab with chemotherapy for treating hormone receptor-positive HER2-negative locally recurrent inoperable or metastatic breast cancer [ID6285]

    Awaiting development [GID-TA11342] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Nivolumab with ipilimumab for untreated advanced hepatocellular carcinoma [ID6239]

    Awaiting development [GID-TA11116] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  12. Ciclosporin ophthalmic solution for treating dry eyes after inadequate response to artificial tears TSID8472

      Status ...

    Technology appraisal guidance
    Topic selection

  13. Etrolizumab for treating moderately to severely active ulcerative colitis [ID3827]

    Awaiting development [GID-TA10717] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]

    Awaiting development [GID-TA10718] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Secukinumab biosimilar for treating plaque psoriasis TSID 11992

      Status ...

    Technology appraisal guidance
    Topic selection